Buspirone


Article Author:
Tyler Wilson


Article Editor:
Jayson Tripp


Editors In Chief:
Chaddie Doerr


Managing Editors:
Avais Raja
Orawan Chaigasame
Carrie Smith
Abdul Waheed
Khalid Alsayouri
Trevor Nezwek
Radia Jamil
Patrick Le
Anoosh Zafar Gondal
Saad Nazir
William Gossman
Hassam Zulfiqar
Hussain Sajjad
Steve Bhimji
Muhammad Hashmi
John Shell
Matthew Varacallo
Heba Mahdy
Ahmad Malik
Sarosh Vaqar
Mark Pellegrini
James Hughes
Beata Beatty
Beenish Sohail
Nazia Sadiq
Hajira Basit
Phillip Hynes


Updated:
2/14/2019 8:35:11 AM

Indications

Buspirone is an anxiolytic first synthesized in 1968 and patented in 1975.  Originally the drug was being developed as an antipsychotic, but found to not be effective for psychosis, but it had anxiolytic features that were useful.  Buspirone has recently come back into favor.[1] This is mostly due to its decreased side-effect profile compared to other anxiolytic treatments. Buspirone is primarily used in the treatment of generalized anxiety disorder (GAD). Typically, it is used as a second-line agent behind selective serotonin reuptake inhibitors (SSRIs) when a patient does not respond to or cannot tolerate the side effects of SSRIs. Buspirone has also been used as an augmentation agent to reduce SSRIs sexual side effects in particular. Unlike benzodiazepines and barbiturates, there is no associated risk of physical dependence or withdrawal with buspirone use due to the lack of effects on GABA receptors. However, buspirone has little efficacy as an acute anxiolytic as clinical effect typically takes 2 to 4 weeks to achieve.[1] Buspirone is FDA approved for the short and long-term treatment of GAD, as well as short-term symptomatic relief of anxiety. It has been shown to be as effective as benzodiazepine treatment for GAD.

The Sequenced Treatment Alternatives to Relieve Depression (STAR*D) trial showed evidence suggesting that buspirone could be effective as augmentation, alongside SSRIs, for unipolar depression. Further studies have also found some utility in subduing the sexual side effects of SSRIs, as well as use as a single agent for the treatment of depression. Although the FDA does not approve these uses, some evidence has suggested the buspirone combined with melatonin has the potential to treat MDD and promote neurogenesis.[2]

It is important to recognize that buspirone has no use in the treatment of the symptoms of withdrawal from benzodiazepines, barbiturates, or alcohol. Again, this relates to the lack of GABA receptor activity. Furthermore, the effects of buspirone have been shown to be diminished in patients who have been previously treated with benzodiazepines.

Mechanism of Action

Buspirone has a high affinity for serotonin 5HT1a receptors where it acts as a partial agonist, which is believed to produce the majority of clinical effects.[1] It also has weak affinity for serotonin 5HT2 receptors and acts as a weak antagonist on dopamine D2 autoreceptors. There is no effect on benzodiazepine GABA receptors. How the partial 5HT1a agonism translates into clinical results remains largely unknown; however, it is suspected to be caused by increased serotonergic activity in the amygdala and other parts of the brain’s anxiety/fear circuitry. Due to the delayed anxiolytic effects seen clinically, buspirone likely provides relief through adaptations in 5HT1a receptors.

Administration

Buspirone is offered in 5-mg, 7.5-mg, 10-mg, 15-mg, and 30-mg oral tablets. The initial recommended dose for GAD treatment is 15 mg per day, given as either 7.5 mg twice per day. or 5 mg three times per day. Every 2 to 3 days, the dosage may be increased by 5 mg until the desired clinical response is reached. The maximum daily dosage is 60 mg per day. In clinical trials, a typical range of therapeutic effect was found between 20 to 30 mg per day of divided doses.

Buspirone has been occasionally used off-label for pediatric anxiety disorders. The dosage has not been well established. In a pilot study of children aged 6 to 14 years, they were started on a daily dose of 5 mg and increased by 5 mg every week up to a maximum daily dose of 20 mg. Another larger study with patients aged 6 to 17 years had a higher maximum daily dose of 60 mg.

Absorption is decreased with food intake; however, concomitant food intake also decreases the amount of the first-pass metabolism of the drug. The net result of taking food with the medication is an increase in the bioavailability. Because of this, patients should be instructed to be consistent in whether they take food along with their medication.

Buspirone is metabolized by cytochrome CYP3A4, so any potential interactions should be assessed before an initial prescription. The measured bioavailability (using the steady-state area under the curve), increased 14-fold in patients with hepatic impairment and 4-fold in patients with renal impairment.

Adverse Effects

A common side effect is dizziness that occurs in over 10% of patients.

The following have been reported in 1% to 10% of patients:

  • Central nervous system (CNS): Abnormal dreams, ataxia, confusion, dizziness, drowsiness, excitement, headache, nervousness, numbness, outbursts of anger, paresthesia 
  • Ophthalmic: Blurred vision 
  • Otic: Tinnitus
  • Cardiovascular: Chest pain
  • Respiratory: Nasal congestion
  • Dermatologic: Diaphoresis, skin rash
  • Gastrointestinal: Diarrhea, nausea, sore throat
  • Neuromuscular and skeletal: Musculoskeletal pain, tremor, weakness

Many of these effects are relieved with the continuation of therapy and with a slow, gradual increase when finding a therapeutic dose. Of note, buspirone has minimal sexual side effects. It has even been shown to help relieve the adverse sexual effects of SSRIs when given as an augmenting agent.

Patients should be warned about the possibility of CNS depression. While rarer, patients should also be informed of the potential for akathisia (likely due to central dopamine antagonism) and serotonin syndrome.

Contraindications

  • Any history of hypersensitivity reaction with buspirone in the past
  • Use of monoamine oxidase inhibitors (MAOI) within 14 days before or after buspirone therapy due to risk of serotonin syndrome and/or elevated blood pressure 
  • Starting buspirone in patients receiving reversible MAOIs such as linezolid or IV methylene blue due to risk of serotonin syndrome

Monitoring

Offer frequent follow-up after initiating treatment to assess for therapeutic and adverse effects. Encourage patients to stay consistent with their medication schedule and whether they take it with food. As mentioned before, a therapeutic effect typically takes 2 to 4 weeks to take effect. Often, many of the adverse effects will lessen over time as well. However, the patient should be closely monitored for signs and symptoms of anaphylaxis, akathisia, and serotonin syndrome.

Being a substrate of CYP3A4, buspirone must be continuously checked for interactions that can alter its plasma concentration. This includes grapefruit juice, which can increase its concentration.

Alcohol use can worsen any CNS depression, and its use should be closely monitored as well.

Toxicity

Relative to other anxiolytics, buspirone has low toxicity and potential for abuse. No deaths have been reported from a buspirone overdose alone. In pharmacological trials, healthy male patients were given up to 375 mg per day and developed nausea, vomiting, dizziness, drowsiness, miosis, and gastric distress. While buspirone overdose typically resolves with complete recovery, high suspicion of additional medication overdose should be maintained and investigated.[3][4][5]

Buspirone is a Category B risk in pregnancy, and it is unknown whether it is present in breast milk. One case report states that buspirone was not transmitted via lactation, but the manufacturer does not recommend breastfeeding while taking the medication.

Enhancing Healthcare Team Outcomes

When considering the implementation of buspirone therapy, it is critical to recognize its strengths and weaknesses mentioned above. If a patient is an appropriate candidate, verify that they are invested in the treatment and have an understanding of the possible risks and benefits. Encourage individuals to be patient at the initiation of therapy and follow up within a month to assess effectiveness.[6][7]


Interested in Participating?

We are looking for contributors to author, edit, and peer review our vast library of review articles and multiple choice questions. In as little as 2-3 hours you can make a significant contribution to your specialty. In return for a small amount of your time, you will receive free access to all content and you will be published as an author or editor in eBooks, apps, online CME/CE activities, and an online Learning Management System for students, teachers, and program directors that allows access to review materials in over 500 specialties.

Improve Content - Become an Author or Editor

This is an academic project designed to provide inexpensive peer-reviewed Apps, eBooks, and very soon an online CME/CE system to help students identify weaknesses and improve knowledge. We would like you to consider being an author or editor. Please click here to learn more. Thank you for you for your interest, the StatPearls Publishing Editorial Team.

Buspirone - Questions

Take a quiz of the questions on this article.

Take Quiz
A male with a generalized anxiety disorder was started on buspirone therapy. This drug is thought to interact with which of the following neurotransmitter systems?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
Which anxiolytic agent acts as a partial agonist on 5-HT receptors and has negligible abuse potential?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
Which of the following is an FDA approved indication for buspirone therapy?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
Which of the following has been shown to negatively impact the efficacy of buspirone therapy in patients with generalized anxiety disorder?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
Which of the following would be a contraindication for initiating buspirone therapy in a patient with generalized anxiety disorder?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
Buspirone exerts its anxiolytic effect through interaction with which of the following receptor systems?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
Which statement reflects a patient's understanding of buspirone?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
Which of the following drugs has minimal sedative effects?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
A patient on short-term treatment for mild anxiety is switched from a diazepam to buspirone. Which of the following is not an advantage of buspirone?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
Which of the following drugs used to combat anxiety states has the least sedative effect?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up

Buspirone - References

References

Buspirone: Back to the Future., Howland RH,, Journal of psychosocial nursing and mental health services, 2015 Nov     [PubMed]
Fava M,Targum SD,Nierenberg AA,Bleicher LS,Carter TA,Wedel PC,Hen R,Gage FH,Barlow C, An exploratory study of combination buspirone and melatonin SR in major depressive disorder (MDD): a possible role for neurogenesis in drug discovery. Journal of psychiatric research. 2012 Dec     [PubMed]
Salimi A,Razian M,Pourahmad J, Analysis of Toxicity Effects of Buspirone, Cetirizine and Olanzapine on Human Blood Lymphocytes: in Vitro Model. Current clinical pharmacology. 2018;     [PubMed]
Alam N,Najam R,Naeem S, Attenuation of methylphenidate-induced sensitization by co-administration of buspirone. Pakistan journal of pharmaceutical sciences. 2016 Mar;     [PubMed]
Catalano G,Catalano MC,Hanley PF, Seizures associated with buspirone overdose: case report and literature review. Clinical neuropharmacology. 1998 Nov-Dec;     [PubMed]
Slee A,Nazareth I,Bondaronek P,Liu Y,Cheng Z,Freemantle N, Pharmacological treatments for generalised anxiety disorder: a systematic review and network meta-analysis. Lancet (London, England). 2019 Jan 31;     [PubMed]
Elrashidi MY,Ebbert JO, Emerging drugs for the treatment of tobacco dependence: 2014 update. Expert opinion on emerging drugs. 2014 Jun;     [PubMed]

Disclaimer

The intent of StatPearls is to provide practice questions and explanations to assist you in identifying and resolving knowledge deficits. These questions and explanations are not intended to be a source of the knowledge base of all of medicine, nor is it intended to be a board or certification review of Nurse-Child Health PN. The authors or editors do not warrant the information is complete or accurate. The reader is encouraged to verify each answer and explanation in several references. All drug indications and dosages should be verified before administration.

StatPearls offers the most comprehensive database of free multiple-choice questions with explanations and short review chapters ever developed. This system helps physicians, medical students, dentists, nurses, pharmacists, and allied health professionals identify education deficits and learn new concepts. StatPearls is not a board or certification review system for Nurse-Child Health PN, it is a learning system that you can use to help improve your knowledge base of medicine for life-long learning. StatPearls will help you identify your weaknesses so that when you are ready to study for a board or certification exam in Nurse-Child Health PN, you will already be prepared.

Our content is updated continuously through a multi-step peer review process that will help you be prepared and review for a thorough knowledge of Nurse-Child Health PN. When it is time for the Nurse-Child Health PN board and certification exam, you will already be ready. Besides online study quizzes, we also publish our peer-reviewed content in eBooks and mobile Apps. We also offer inexpensive CME/CE, so our content can be used to attain education credits while you study Nurse-Child Health PN.